Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 18, 2025 • 10:51 AM ET

Date/Time Source News Release
06/16/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule
05/29/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital
05/19/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital
05/13/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital
05/08/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Announces Reverse Stock Split
05/07/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital
03/25/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer's Disease to take Place at Massachusetts General Hospital
03/18/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital
03/11/2025 08:00 AM EDT GlobeNewswire Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital
03/04/2025 08:10 AM EST GlobeNewswire Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
Page

Additional News

As of June 18, 2025 • 10:51 AM ET

Date/Time Source News Release
05/30/2025 01:01 PM EDT PRISM News PRISM Mid-Day Movers: Biopharma Results and Enhanced Coverage for AI Cybersecurity Drive Index Movement
05/29/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Lithium Treatment Innovation and Feeding Tube Tech Fuel Index Gains
05/29/2025 10:25 AM EDT BioMedWire Alzamend Neuro Inc. (NASDAQ: ALZN) Targets Transformative Mental Health Breakthroughs
05/29/2025 10:04 AM EDT 24/7 Market News Hot Stocks to Watch Today- May 29, 2025
05/29/2025 09:15 AM EDT BioMedWire BioMedNewsBreaks - Alzamend Neuro, Inc. (NASDAQ: ALZN) Doses First Patient in Phase II Trial for Next-Gen Lithium Therapy AL001
05/13/2025 12:32 PM EDT PRISM News Alzamend Neuro Advances Alzheimer's Drug Candidate into Phase II Trial
05/13/2025 09:42 AM EDT 24/7 Market News Alzamend Neuro's AL001 "Lithium in Brain" Study Kicks Off at MGH, Aiming to Redefine Alzheimer's and Mood Disorder Treatments
05/12/2025 09:00 AM EDT KlickAnalytics ALZN announced stock split 1-9
05/09/2025 12:31 PM EDT SeekingAlpha Healthcare stocks that could be poised for a rebound
05/08/2025 08:20 AM EDT SeekingAlpha Alzamend Neuro to conduct reverse stock split
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.